| Primary |
| Depression |
27.3% |
| Urinary Incontinence |
22.7% |
| Diabetic Neuropathy |
13.6% |
| Anxiety |
9.1% |
| Diabetes Mellitus |
4.5% |
| Hyperlipidaemia |
4.5% |
| Migraine |
4.5% |
| Muscle Spasms |
4.5% |
| Stress Urinary Incontinence |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
|
| Cardio-respiratory Arrest |
11.5% |
| Completed Suicide |
7.7% |
| Hepatic Enzyme Increased |
7.7% |
| Hypertension |
7.7% |
| Medication Error |
7.7% |
| Agitation |
3.8% |
| Bedridden |
3.8% |
| Blindness |
3.8% |
| Confusional State |
3.8% |
| Dizziness |
3.8% |
| Drug Interaction |
3.8% |
| Electrocardiogram Qt Prolonged |
3.8% |
| Feeding Tube Complication |
3.8% |
| Gastrointestinal Tube Insertion |
3.8% |
| Haemorrhoidal Haemorrhage |
3.8% |
| Hot Flush |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Muscular Weakness |
3.8% |
| Nausea |
3.8% |
| Osteomyelitis |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
58.0% |
| Depression |
9.1% |
| Suicide Attempt |
7.5% |
| Completed Suicide |
7.4% |
| Major Depression |
2.4% |
| Anxiety |
1.7% |
| Hallucination, Auditory |
1.7% |
| Neuralgia |
1.6% |
| Diabetic Neuropathy |
1.1% |
| Pain |
1.1% |
| Psychotic Disorder |
1.1% |
| Agitated Depression |
0.9% |
| Depressed Mood |
0.9% |
| Device Therapy |
0.9% |
| Foetal Exposure During Pregnancy |
0.9% |
| Hiv Infection |
0.9% |
| Insomnia |
0.9% |
| Type 1 Diabetes Mellitus |
0.9% |
| Anaesthesia |
0.6% |
| Attention Deficit/hyperactivity Disorder |
0.6% |
|
| Completed Suicide |
30.9% |
| Death |
10.1% |
| Optic Neuritis |
8.6% |
| Toxicity To Various Agents |
7.2% |
| Cardio-respiratory Arrest |
5.8% |
| Maternal Exposure During Pregnancy |
3.6% |
| Serotonin Syndrome |
3.6% |
| Drug Interaction |
2.9% |
| Fatigue |
2.9% |
| Hypoglycaemia |
2.9% |
| Medication Error |
2.9% |
| Nausea |
2.9% |
| Respiratory Arrest |
2.9% |
| Bezoar |
2.2% |
| Intentional Drug Misuse |
2.2% |
| Poisoning |
2.2% |
| Syncope |
2.2% |
| Arrhythmia |
1.4% |
| Cardiac Arrest |
1.4% |
| Drug Level Increased |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.2% |
| Pain |
12.3% |
| Depression |
9.4% |
| Schizophrenia |
7.0% |
| Hypertension |
5.2% |
| Rheumatoid Arthritis |
4.6% |
| Diabetes Mellitus |
3.2% |
| Headache |
2.4% |
| Major Depression |
2.1% |
| Multiple Sclerosis |
2.1% |
| Anxiety |
2.0% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Idiopathic Thrombocytopenic Purpura |
1.7% |
| Insomnia |
1.7% |
| Smoking Cessation Therapy |
1.4% |
| Acute Myeloid Leukaemia |
1.2% |
| Back Pain |
1.2% |
| Cardiac Failure |
1.2% |
| Multiple Myeloma |
1.2% |
| Hiv Infection |
1.1% |
|
| Nausea |
7.6% |
| Fall |
6.3% |
| Heart Rate Decreased |
6.3% |
| Urinary Tract Infection |
6.3% |
| Acute Generalised Exanthematous Pustulosis |
5.1% |
| Acute Sinusitis |
5.1% |
| Depression |
5.1% |
| Headache |
5.1% |
| Hepatotoxicity |
5.1% |
| Hypertension |
5.1% |
| Hypoaesthesia |
5.1% |
| Platelet Count Decreased |
5.1% |
| Vomiting |
5.1% |
| Weight Increased |
5.1% |
| Back Pain |
3.8% |
| Breast Cancer |
3.8% |
| Diarrhoea |
3.8% |
| Dizziness |
3.8% |
| Drug Ineffective |
3.8% |
| Injection Site Pain |
3.8% |
|
| Interacting |
| Depression |
17.2% |
| Ill-defined Disorder |
14.1% |
| Complex Regional Pain Syndrome |
12.5% |
| Post Herpetic Neuralgia |
10.9% |
| Panic Disorder |
6.3% |
| Attention Deficit/hyperactivity Disorder |
4.7% |
| Product Used For Unknown Indication |
4.7% |
| Urinary Tract Infection |
4.7% |
| Hypertension |
3.1% |
| Hypervigilance |
3.1% |
| Intervertebral Disc Protrusion |
3.1% |
| Sleep Disorder |
3.1% |
| Stress Urinary Incontinence |
3.1% |
| Breast Cancer |
1.6% |
| Dementia |
1.6% |
| Disturbance In Attention |
1.6% |
| Hypothyroidism |
1.6% |
| Sleep Disorder Therapy |
1.6% |
| Urinary Tract Disorder |
1.6% |
|
| Drug Interaction |
25.0% |
| Suicidal Ideation |
14.3% |
| Serotonin Syndrome |
10.7% |
| Agitation |
7.1% |
| Off Label Use |
7.1% |
| Stress Cardiomyopathy |
7.1% |
| Amenorrhoea |
3.6% |
| Breast Cancer Recurrent |
3.6% |
| Decreased Appetite |
3.6% |
| Delirium |
3.6% |
| Depression |
3.6% |
| Drug Screen False Positive |
3.6% |
| Loss Of Consciousness |
3.6% |
| Restlessness |
3.6% |
|
